{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:57:20Z","timestamp":1780509440497,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Capital Medical University Research Cultivation Fund","award":["PYZ23117"],"award-info":[{"award-number":["PYZ23117"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11096-024-01762-6","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:02:02Z","timestamp":1718899322000},"page":"1225-1231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic influence of meningioma on cisplatin resistance: a Mendelian randomization analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Kefu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"issue":"14","key":"1762_CR1","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1200\/JCO.22.02804","volume":"41","author":"TE Stinchcombe","year":"2023","unstructured":"Stinchcombe TE. Flashback foreword: cisplatin\/pemetrexed in non-small-cell lung cancer. J Clin Oncol. 2023;41(14):2455\u20136.","journal-title":"J Clin Oncol"},{"issue":"13","key":"1762_CR2","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1200\/JCO.22.00980","volume":"41","author":"VM Patil","year":"2023","unstructured":"Patil VM, Noronha V, Menon N, et al. Results of phase III randomized trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer, unsuitable for cisplatin-based chemoradiation. J Clin Oncol. 2023;41(13):2350\u201361.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1762_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-022-02315-3","volume":"41","author":"F Lin","year":"2022","unstructured":"Lin F, Li X, Wang X, et al. Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2\/ITGB6 signaling axis in ovarian cancer. J Exp Clin Cancer Res. 2022;41(1):129.","journal-title":"J Exp Clin Cancer Res"},{"key":"1762_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102054","volume":"88","author":"G de Vries","year":"2020","unstructured":"de Vries G, Rosas-Plaza X, van Vugt M, et al. Testicular cancer: determinants of cisplatin sensitivity and novel therapeutic opportunities. Cancer Treat Rev. 2020;88:102054.","journal-title":"Cancer Treat Rev"},{"key":"1762_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh S. Cisplatin: the first metal based anticancer drug. Bioorg Chem. 2019;88: 102925.","journal-title":"Bioorg Chem"},{"issue":"1","key":"1762_CR6","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1038\/s41467-020-17958-z","volume":"11","author":"YW Kong","year":"2020","unstructured":"Kong YW, Dreaden EC, Morandell S, et al. Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints. Nat Commun. 2020;11(1):4124.","journal-title":"Nat Commun"},{"key":"1762_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.579599","volume":"10","author":"K Huntoon","year":"2020","unstructured":"Huntoon K, Toland AMS, Dahiya S. Meningioma: a review of clinicopathological and molecular aspects. Front Oncol. 2020;10: 579599.","journal-title":"Front Oncol"},{"issue":"3","key":"1762_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/biomedicines9030319","volume":"9","author":"C Ogasawara","year":"2021","unstructured":"Ogasawara C, Philbrick BD, Adamson DC. Meningioma: a review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines. 2021;9(3):319.","journal-title":"Biomedicines."},{"issue":"3","key":"1762_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14737175.2018.1429920","volume":"18","author":"C Apra","year":"2018","unstructured":"Apra C, Peyre M, Kalamarides M. Current treatment options for meningioma. Expert Rev Neurother. 2018;18(3):241\u20139.","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"1762_CR10","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2015.1.FOCUS14757","volume":"38","author":"SQ Sun","year":"2015","unstructured":"Sun SQ, Hawasli AH, Huang J, et al. An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas. Neurosurg Focus. 2015;38(3):E3.","journal-title":"Neurosurg Focus"},{"key":"1762_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainres.2007.10.074","volume":"1188","author":"HH Al-Khalaf","year":"2008","unstructured":"Al-Khalaf HH, Lach B, Allam A, et al. Expression of survivin and p16(INK4a)\/Cdk6\/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells. Brain Res. 2008;1188:25\u201334.","journal-title":"Brain Res"},{"issue":"7","key":"1762_CR12","doi-asserted-by":"publisher","first-page":"a040980","DOI":"10.1101\/cshperspect.a040980","volume":"11","author":"BA Ference","year":"2021","unstructured":"Ference BA, Holmes MV, Smith GD. Using Mendelian randomization to improve the design of randomized trials. Cold Spring Harb Perspect Med. 2021;11(7):a040980.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3\u20134","key":"1762_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/hmg\/ddab029","volume":"30","author":"AJ Mulford","year":"2021","unstructured":"Mulford AJ, Wing C, Dolan ME, et al. Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations. Hum Mol Genet. 2021;30(3\u20134):305\u201317.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"1762_CR14","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/sim.4197","volume":"30","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat Med. 2011;30(11):1312\u201323.","journal-title":"Stat Med"},{"key":"1762_CR15","doi-asserted-by":"publisher","unstructured":"Hemani G, Bowden J, Haycock P, et al. Automating Mendelian randomization through machine learning to construct a putative causal map of the human phenome. BioRxiv. 2017;173682. [preprint]. Available from https:\/\/doi.org\/10.1101\/173682. Accessed 1 Apr 2024","DOI":"10.1101\/173682"},{"issue":"7","key":"1762_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"1762_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"22","key":"1762_CR18","doi-asserted-by":"publisher","first-page":"13397","DOI":"10.1021\/acs.jmedchem.0c00950","volume":"63","author":"C Yu","year":"2020","unstructured":"Yu C, Wang Z, Sun Z, et al. Platinum-based combination therapy: molecular rationale, current clinical uses, and future perspectives. J Med Chem. 2020;63(22):13397\u2013412.","journal-title":"J Med Chem"},{"issue":"6","key":"1762_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jamaoncol.2023.0197","volume":"9","author":"DL Richardson","year":"2023","unstructured":"Richardson DL, Eskander RN, O\u2019Malley DM. Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance: a narrative review. JAMA Oncol. 2023;9(6):851\u20139.","journal-title":"JAMA Oncol"},{"key":"1762_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","volume":"106","author":"L Amable","year":"2016","unstructured":"Amable L. Cisplatin resistance and opportunities for precision medicine. Pharmacol Res. 2016;106:27\u201336.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1762_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12967-022-03372-0","volume":"20","author":"Q Sui","year":"2022","unstructured":"Sui Q, Chen Z, Hu Z, et al. Cisplatin resistance-related multi-omics differences and the establishment of machine learning models. J Transl Med. 2022;20(1):171.","journal-title":"J Transl Med"},{"issue":"4","key":"1762_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ijc.2910640402","volume":"64","author":"JL Wang","year":"1995","unstructured":"Wang JL, Zhang ZJ, Hartman M, et al. Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction\/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples. Int J Cancer. 1995;64(4):223\u20138.","journal-title":"Int J Cancer"},{"issue":"10","key":"1762_CR23","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2174\/1570159X21666230511123157","volume":"21","author":"X Liu","year":"2023","unstructured":"Liu X, Zhang H, Wang C, et al. Tumor-selective blockade of CD47 signaling with CD47 antibody for enhanced anti-tumor activity in malignant meningioma. Curr Neuropharmacol. 2023;21(10):2159\u201373.","journal-title":"Curr Neuropharmacol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01762-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01762-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01762-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T08:51:24Z","timestamp":1726217484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01762-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01762-6","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no have conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}